Request for information/Detection of CXCL13 chemoquine in cerebrospinal fluid Text automatically translated in your browsing language Automatically translated

By that request for information, the HUS Group (‘HUS’) seeks to identify the market supply of laboratory methods for the detection of CXCL13 chemokine in cerebrospinal fluid. Research abbreviation: Li-CXCL13 Research title: Li-CXCL13 chemokine content INSTRUCTIONS FOR RESPONSIBILITY If you have a product(s) suitable for the analytics described above and are interested in participating in a market dialogue, please send a message to kilpailutus.laboratorio@hus.fi with the subject "Response to request for information CXCL13 chemokini". Please provide the following information and answers: 1) Do you have a suitable CXCL13 cemoquine product(s) in your range? 2) Brief description of the solution in your assortment 3) Is the product in your assortment in accordance with IVDR regulation CE-IVD marked for the detection of CXCL13 chemokine in cerebrospinal fluid? 4) Product brochure as appendix 5) Is a product presentation possible? 6) Is a trial run possible? What is the price of a possible trial? 7) Contact person and e-mail address for possible market dialogue In addition, we are interested in market participants' solutions related to the environmental impacts of products, production and supply chain as well as the responsibility of operations. TIME OF THE REPLY We would like to receive your reply as described above no later than 10 March 2025. The Contracting Entity reserves the right to arrange a more detailed market dialogue with the registered parties at its discretion. The purpose of the information request is to obtain comprehensive information about the products so that a possible call for tenders can be carried out appropriately. The contracting entity does not undertake to carry out the procurement. If the purchase is carried out, changes to the content of this notice are possible. The contracting entity reserves the right to divide the procurement into lots. This request for information does not constitute a contract notice, a prior information notice or a call for tenders and the publication of this notice does not constitute a call for tenders. Responding to a request for information is not a prerequisite for participating in a possible subsequent tendering procedure, and responding to a request for information does not affect the tenderer’s position in a possible tendering procedure. Participants in the market dialogue shall not be entitled to compensation for their participation. Responses given in the market dialogue shall not be binding on the respondent in any subsequent procurement. The information gathered through the market dialogue will remain confidential and will only be used to plan the procurement. Text automatically translated in your browsing language Automatically translated

33696500 - Laboratory reagents